A case of neurofibromatosis type 1 with clival chordoma
DOI:
https://doi.org/10.18203/2320-6012.ijrms20241928Keywords:
Neurofibromatosis type-1, Clival chordoma, Neurofibromatosis, Von Recklinghausen diseaseAbstract
Neurofibromatosis type-1 is an autosomal dominant tumour syndrome with a high clinical susceptibility to malignancies, especially nervous system malignancies. Here, we reported a case of neurofibromatosis type-1 in a male in his 50s, who presented with generalised weakness, headache associated with ear pain, a feeling of heaviness of the head, and giddiness for a duration of 1 week. On examination, he had axillary freckling and multiple neurofibromas over his body. Nystagmus and dysdiadokokinesia were present. MRI brain revealed an enhancing lesion in the sphenoid and clivus, extending into the sellar and supra-sellar region. The possibility of pituitary adenoma and clival chordoma were considered. He was referred to Neurosurgery and underwent Trans-nasal Trans-sphenoidal near-total resection of the tumour. Biopsy of the lesion was indicative of conventional clival chordoma, which is rarely reported with NF-1. The post-operative period was uneventful and the patient is planned for regular follow-up to detect recurrence.
Metrics
References
Friedman JM. Neurofibromatosis 1. In: Adam MP, Feldman J, Mirzaa GM, eds. Seattle (WA): University of Washington, Seattle: GeneReviews; 1998.
Korf BR. Malignancy in neurofibromatosis type 1. Oncologist. 2000;5(6):477-85.
Walcott BP, Nahed BV, Mohyeldin A, Coumans JV, Kahle KT, Ferreira MJ. Chordoma: current concepts, management, and future directions. Lancet Oncol. 2012;13(2):69-76.
Khawaja AM, Venkatraman A, Mirza M. Clival chordoma: case report and review of recent developments in surgical and adjuvant treatments. Pol J Radiol. 2017;82:670-5.
Wallace MR, Marchuk DA, Andersen LB, Letcher R, Odeh HM, Saulino AM, et al. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science. 1990;249(4965):181-6.
Pál E, Gömöri EE, Gáti I. Neurofibromatosis and glioblastoma in a case of multiple sclerosis. Eur J Neurol. 2001;8(6):717-8.
Jeong TS, Yee GT. Glioblastoma in a patient with neurofibromatosis type 1: a case report and review of the literature. Brain Tumor Res Treat. 2014;2(1):36-8.
Varghese P, Jalal MJ. A rare case of neurofibromatosis - type 1. Asian J Neurosurg. 2015;10(4):344-7.
McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM. Chordoma: incidence and survival patterns in the United States, 1973-1995. Cancer Causes Control. 2001;12(1):1-11.
Chen G, Li M, Xu W, Wang X, Feng M, Wang R, et al. Surgical outcomes of clival chordoma through endoscopic endonasal approach: a single-center experience. Front Endocrinol (Lausanne). 2022;13.
Vujovic S, Henderson S, Presneau N, Odell E, Jacques T, Tirabosco R, et al. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol. 2006;209(2):157-65.
Yang XR, Ng D, Alcorta DA, Liebsch NJ, Sheridan E, Li S, et al. T (brachyury) gene duplication confers major susceptibility to familial chordoma. Nat Genet. 2009;41(11):1176-8.
Clynes MM, Duke EJ. Altered pyrimidine-salvage metabolism in a 5-fluorouracil-resistant mutant of Drosophila melanogaster. Biochem Soc Trans. 1976;4(5):900-1.
Downloads
Published
How to Cite
Issue
Section
